FORM 4
[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response...
0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Toal Sheamus
2. Issuer Name and Ticker or Trading Symbol

New York & Company, Inc. [ NWY ]
5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                      _____ 10% Owner
__ X __ Officer (give title below)      _____ Other (specify below)
EVP and CFO
(Last)          (First)          (Middle)

330 W. 34TH STREET, 9TH FLOOR
3. Date of Earliest Transaction (MM/DD/YYYY)

8/22/2016
(Street)

NEW YORK, NY 10001
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock   8/22/2016     A    20000   (1) A $0   248644   D    
Common Stock   8/31/2016     F    1345   (2) D $2.25   247299   (3) D    

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Appreciation Rights   $2.15   8/22/2016     A      115000         (4) 8/22/2026   Common Stock   115000   $0   115000   D    

Explanation of Responses:
( 1)  The reporting person was awarded restricted stock which vests on August 22, 2019.
( 2)  Represents a transaction involving a disposition to the Company of equity securities to satisfy tax withholding obligations upon the vesting of deferred stock units.
( 3)  Includes 111,537 shares of common stock; 11,268 vested deferred stock units; 8,864 deferred stock units which vest on April 30, 2017; 2,404 deferred stock units which vest on August 31, 2018; 50,000 shares of restricted stock which vest on October 22, 2016; 21,613 shares of restricted stock which vest on August 25, 2017; 21,613 shares of restricted stock which vest on August 25, 2018; and 20,000 shares of restricted stock which vest on August 22, 2019.
( 4)  The reporting person was awarded stock appreciation rights (SARs) which vest as follows: 28,750 on August 22, 2017; 28,750 on August 22, 2018, and 57,500 on August 22, 2019. Each SAR represents the right to receive a payment measured by the increase in the fair market value of one share of common stock from the date of grant of the SAR to the date of exercise of the SAR. Upon exercise the SARs will be settled in stock.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
Toal Sheamus
330 W. 34TH STREET
9TH FLOOR
NEW YORK, NY 10001


EVP and CFO

Signatures
Linda Gormezano, attorney-in-fact /s/ Linda Gormezano 8/31/2016
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
New York & Company (NYSE:NWY)
Historical Stock Chart
From Feb 2024 to Mar 2024 Click Here for more New York & Company Charts.
New York & Company (NYSE:NWY)
Historical Stock Chart
From Mar 2023 to Mar 2024 Click Here for more New York & Company Charts.